MJFF is today announcing the launch of three new funding programs focused on driving research toward transformative treatments and a cure for Parkinsonís disease (PD). Two programs will promote critical work on the promising therapeutic targets LRRK2 and Parkin, while a third program allows researchers to propose developing biomarkers of cognitive impairment in PD. The new funding opportunities are open to both academic and industry researchers.
In addition to these new programs, five other programs are currently open and accepting applications. Interested researchers should check out the complete list and apply for funding at https://www.michaeljfox.org/research/apply-for-grant.html.†